Trump Ties 340B To High Prices, Asks For Feedback On Changing Program

By Michelle M. Stein / May 11, 2018 at 7:24 PM
President Donald Trump's drug price containment plan blames the 340B drug discount program in part for high drug prices, and asks for feedback in a number of areas including how the program's growth affects list prices and insurers, whether the definition of a 340B patient should be changed and how to better prohibit duplicate discounts. Both the definition of a patient and duplicate discounts were covered in guidance initially published by the Obama administration that Trump's Health Resources and Services...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.